title: Plasma dabigatran activity one week after discontinuation despite normal renal function.
authors.forename: Jecko
authors.initials: J
authors.lastname: Thachil
authors.forename: Gill
authors.initials: G
authors.lastname: Pike
authors.forename: Lynne
authors.initials: L
authors.lastname: Keighley-Jones
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Nash
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000009:adverse effects / Q000493:pharmacokinetics*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000009:adverse effects / Q000493:pharmacokinetics*; D000069604:Dabigatran; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran